Arax Advisory Partners’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Arax Advisory Partners's PGEN Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Precigen (PGEN) in Q2 2026: 50,762 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #1994 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in PGEN as recently as Q4 2025.
Arax Advisory Partners first reported a position in PGEN in Q2 2024 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Arax Advisory Partners held 50,762 shares of Precigen worth $289K as of Q2 2026.
- Precigen was a new Arax Advisory Partners position in Q2 2026.
- Precigen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1994 holding.
- Arax Advisory Partners first reported a position in Precigen in Q2 2024 and has held it in 4 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.